Initial assessment
When the clinical history suggests allergic disease, structured screening should be initiated. Consider respiratory/ocular symptoms (asthma, rhinitis, conjunctivitis), food-related manifestations (abdominal pain, vomiting, diarrhoea, food refusal, faltering growth, eczema), reactions to medicines, latex and Hymenoptera venom. Confirm the temporal relationship with exposure and consider differential diagnoses.
Skin prick testing
If available and not contraindicated, skin prick testing is the first step. A positive result, when consistent with the clinical history, confirms sensitisation and guides avoidance measures and possible immunotherapy. If negative but clinical suspicion persists, proceed with specific IgE testing. When skin prick testing is unavailable or contraindicated, laboratory tests should be preferred.
When to avoid skin prick testing
Avoid skin prick testing when it is essential to continue antihistamines/tricyclic antidepressants, when extensive dermatosis/dermographism is present, or when there is a high risk of an anaphylactic reaction to the allergen. In these scenarios, use serum specific IgE testing.
Specific IgE panels (laboratory screening)
Phadiatop (inhalants): a mixture of house dust mites, animal epithelia, fungi and pollens; useful for screening respiratory atopy.
Fx5 (foods): a mixture of common food allergens (e.g. egg, milk, fish, wheat, peanut, soy); useful for screening food allergy. Reporting is qualitative/semi-quantitative, with a usual threshold of 0.35 PAU/l.
Interpretation of panels
Values above the threshold suggest atopy/sensitisation; increasing classes (1–6) reflect a higher clinical probability. A positive panel guides the selection of individual specific IgE tests by allergen group. A negative panel with strong clinical suspicion requires reassessment (alternative diagnoses, seasonal repeat testing or an alternative method).
Individual specific IgE — indications
Request individual specific IgE to: confirm the diagnosis when the clinical history is convincing; guide avoidance measures; assess patients unable to undergo skin prick testing; investigate negative skin prick testing with high clinical suspicion; confirm sensitisation before immunotherapy; monitor tolerance acquisition in food allergy or response to desensitisation. Select 1–2 allergens per group, adjusted to the clinical history and epidemiological context.
Total IgE — when to request
Not indicated for routine screening of respiratory or food allergy. Reserve for specific situations: assessment/follow-up of allergic bronchopulmonary aspergillosis, determination of the initial omalizumab dose and hyper-IgE syndromes.
Conclusion
Recommended pathway: clinical history ➝ skin prick testing (if possible) ➝ IgE screening panels (Phadiatop/Fx5) ➝ individual specific IgE according to indication; reserve total IgE for specific cases. This sequence standardises diagnosis, avoids indiscriminate testing and supports decisions regarding avoidance and immunotherapy.